Parathyroid hormone (PTH) is measured by Roche electrochemiluminescent immunoassay. This test is FDA cleared but is not labeled for use with FNA fluid. The performance characteristics of this test were determined by ARUP.
Compliance Statement B
: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.